NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE22615 Query DataSets for GSE22615
Status Public on Mar 16, 2011
Title Genomic alterations of chromosome 11 induce transcriptomic dysregulation in aggressive and malignant prolactin tumours
Organism Homo sapiens
Experiment type Genome variation profiling by SNP array
Summary Pituitary tumors are generally considered as benign. However, many are invasive (45 to 55%) and some are described as aggressive with a high proliferation rate and short post-operative time to recurrence and 0.2% metastasize. The molecular events associated to the progression of the pituitary tumor toward an aggressive and malignant phenotype is still unresolved. To bring new hypothesis on signaling pathways associated to the tumor progression, we applied a wide genome analysis approach combining transcriptome analysis and CGH analysis on the same 13 prolactin tumours classified as non-invasive (n=5), invasive (n=2) and agressive-invasive tumors (n=6). In 5/6 agressive-invasive tumours a loss of a common region in the p arm of the chromosome 11 was detected. This region extending from position 14.9 to position 46.5 Mb harbours the cytobands 11p15.2, 11p15.1, 11p14.3, 11p14.2, 11p14.1, 11p13, 11p12 and 11p11.2. In 3 of these 5 tumours considered as carcinomas because of the presence of metastasis, an allelic loss is also observed in the 11q arm. The combination of data coming from genome structure exploration and transcriptomic analysis showed that allelic loss impact the expression of genes harbored in the imbalanced region. Data filtering strategy allowed us to highlight among the 139 genes harbored in the 11p region loss, 5 genes (DGKZ, CD44, TSG101, GTF2H1 and HTATIP2) that could be candidate gene for triggering the progression of prolactin tumour toward an aggressive and malignant phenotype. Finally, specific DNA alterations give one molecular argument more to consider agressive-invasive tumour and carcinomas as a distinct step in progression of the pituitary tumours.
 
Overall design Copy number analysis of Affymetrix Genome-Wide Human SNP Array 6.0 was performed for 13 prolactin tumors, 6 aggressive-invasive, 2 invasive, 5 non-invasive. The same analysis was performed for one normal pituitary and one genomic DNA called "reference 103" from Affymetrix.
 
Contributor(s) WIERINCKX A, ROCHE M, LEGRAS-LACHUER C, NAZARET N, CROZE S, RAVEROT G, REY C, AUGER C, JOUANNEAU E, CHANSON P, TROUILLAS J, LACHUER J
Citation(s) 21251114
Submission date Jun 29, 2010
Last update date Jan 08, 2019
Contact name Joël LACHUER
E-mail(s) lachuer@univ-lyon1.fr
Phone 04 72 91 34 93
Organization name INSERM
Department U842
Street address 16 avenue du Doyen Lépine
City BRON
ZIP/Postal code 69676
Country France
 
Platforms (1)
GPL6801 [GenomeWideSNP_6] Affymetrix Genome-Wide Human SNP 6.0 Array
Samples (15)
GSM560908 agressive-invasive prolactin pituitary tumours 1
GSM560909 agressive-invasive prolactin pituitary tumours 2
GSM560910 agressive-invasive prolactin pituitary tumours 3
This SubSeries is part of SuperSeries:
GSE32191 Genomic alterations of chromosome 11 induce transcriptome dysregulation in aggressive and malignant prolactin tumours
Relations
BioProject PRJNA153905

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE22615_RAW.tar 635.8 Mb (http)(custom) TAR (of CEL, CHP)
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap